Bausch Health
BHC
#3383
Rank
โ‚ฌ3.18 B
Marketcap
8,65ย โ‚ฌ
Share price
-0.85%
Change (1 day)
34.94%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Bausch Health (BHC) Fails to deliver data

Key failure to deliver metrics for Bausch Health :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Bausch Health (BHC) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Bausch Health (BHC) - since 2018

Volume in USD (price x number of shares), data since 2018

Bausch Health (BHC) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚ฌ20.81 M-57.46%
2023โ‚ฌ48.92 M-67.42%
2022โ‚ฌ0.15 B134.23%
2021โ‚ฌ64.09 M-45.29%
2020โ‚ฌ0.11 B13.03%
2019โ‚ฌ0.10 B100.86%
2018โ‚ฌ51.6 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚ฌ0.06 Mโ‚ฌ0.41 M๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.47 Mโ‚ฌ63.77 M๐Ÿ‡บ๐Ÿ‡ธ USA